immunotherapy in the evolving mibc treatment landscape
Published 3 years ago • 70 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
2:03
the evolution of bladder cancer treatment and the immuno-oncology era
-
1:08:04
understanding the evolving treatment landscape in bladder cancer
-
4:00
overview of urothelial carcinoma treatment landscape – the promise of immunotherapy
-
1:10
the difficulties in treating bladder cancer with immunotherapy
-
0:44
role of immunotherapy in bladder cancer
-
1:18
updates from keynote-905: immunotherapy cystectomy vs cystectomy alone in mibc
-
4:34
endometrial cancer uterus fda approved treatment - dr robert debernardo, md
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
5:49
dr. roger li on the growing role of neoadjuvant immunotherapy in mibc
-
3:31
the use of immunotherapy as a first-line therapy for bladder cancer
-
19:21
immunotherapy for muscle invasive bladder cancer
-
9:12
immunotherapy for nmibc: emerging and expanding indications
-
6:49
the evolving landscape in the management of high-risk non-muscle-invasive bladder cancer
-
2:07
dr. o’donnell on the evolution of immunotherapy in metastatic bladder cancer
-
0:47
expert highlights next steps to evolve the treatment landscape of urothelial cancer
-
23:44
a review of aua/suo/astro guidelines for muscle invasive bladder cancer (mibc)
-
4:42
bladder-sparing trimodality therapy for muscle-invasive bladder cancer
-
44:45
systemic treatment of bladder cancer: the benefits of clinical pathways